Ashlee Ford Versypt receives $2.1 million NIH grant renewal

ANFV grant.

The balance between tissue degradation and tissue formation that Professor Ford Versypt’s research examines.

Published October 16, 2026

UB researcher Ashlee Ford Versypt has received a $2.1 million grant from the National Institutes of Health to study how diseases interfere with the complex balance between the growth and break-up of tissues occurring in normal healthy conditions.

Print
“With this NIH support, my lab will continue to produce high quality scientific research results and to develop interdisciplinary computational biomedical research scholars.”
University at Buffalo, School of Engineering and Applied Sciences

The Maximizing Investigators’ Research Award (MIRA) R35 funding mechanism within the National Institute of General Medicine Sciences funds the investigator’s overall research program rather than funding a single project. This grant renewal covers her lab’s efforts to develop computational models for multiscale tissue damage and pharmacological treatments.

The team is also developing a suite of machine learning approaches to optimize drug delivery and to calibrate models to modern data types for cell migration, bulk and single cell transcriptomics, and spatial biology. They apply these techniques to investigate processes that are present across a multitude of conditions, approaching them from cellular and tissue levels up to the scale of the whole body.

The team studies tissue remodeling and damage in various human, animal, and engineered tissue microenvironments. The long-term goals are to better predict how to promote regeneration across different tissue systems in the body and optimize treatments. This will enable better treatment and reduce the impact of those conditions on patients.